Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Scientists at Duke University target breast cancer
January 1st, 2009
According to a study from the United States, "Expression of estrogen-related receptor alpha (ERR(x) has recently been shown to carry negative prognostic significance in breast and ovarian cancers. The specific role of this orphan nuclear receptor in tumor growth and progression, however, is yet to be fully understood." "The significant homology between estrogen receptor alpha (ER(alpha) and ERR alpha initially suggested that these receptors may have similar transcriptional targets. Using the well-characterized ER alpha-positive MCF-7 breast cancer cell line, we sought to gain a genome-wide picture of ER alpha-ERR alpha. cross-talk using an unbiased microarray approach....
Source: Women's Health Weekly (2009-01-01)
|
